IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026)
IDEAYA Biosciences' Research & Development came in at $121.58 million for Q3 2026, up 46.5% from $82.99 million a year earlier and up 46.5% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, IDEAYA Biosciences reported Research & Development of $386.89 million, up 5.1% year-over-year; for FY2025, it came in at $314.7 million, up 6.8% from FY2024.
- Research & Development has increased in each of the last eight years, with a five-year compound annual growth rate of 51.3% (FY2020 to FY2025).
- Going back by year, Research & Development was $294.67 million in FY2024 (+127.5%), $129.51 million in FY2023 (+44.6%), $89.54 million in FY2022 (+54.0%) and $58.16 million in FY2021 (+46.5%).
- The Q3 2026 figure represents the highest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 58.0% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 261.6%), and the weakest in Q4 2025 (a decline of 38.2%).
- Business Quant data shows IDYA's Research & Development at $82.99 million (Q2 2026), $95.73 million (Q1 2026) and $86.6 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | IDEAYA Biosciences | 3.30 Bn | 317.16 Mn | - | 121.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 121.58 Mn |
| Jun 30, 2026 | 108.69 Mn |
| Mar 31, 2026 | 95.73 Mn |
| Dec 31, 2025 | 86.60 Mn |
| Sep 30, 2025 | 82.99 Mn |
| Jun 30, 2025 | 74.23 Mn |
| Mar 31, 2025 | 70.89 Mn |
| Dec 31, 2024 | 140.18 Mn |
| Sep 30, 2024 | 57.15 Mn |
| Jun 30, 2024 | 54.53 Mn |
| Mar 31, 2024 | 42.81 Mn |
| Dec 31, 2023 | 38.77 Mn |
| Sep 30, 2023 | 33.70 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 27.86 Mn |
| Dec 31, 2022 | 24.71 Mn |
| Sep 30, 2022 | 22.37 Mn |
| Jun 30, 2022 | 22.80 Mn |
| Mar 31, 2022 | 19.66 Mn |
| Dec 31, 2021 | 16.11 Mn |
API Access
IDEAYA Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();